MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-UK-06-0002547
Staywell Formulation Private Limited
Staywell Formulation Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹3.54 Lakh
▼ 100% YoY
Net loss · FY 2024
₹76.67 Lakh
Latest filing
EBITDA · FY 2024
-₹17.82 Lakh
Latest filing
Authorised capital
₹3 Cr
Registered with MCA
Paid-up capital
₹2.84 Cr
Issued & subscribed
Open charges
₹11.8 Cr
Satisfied ₹6.6 Cr
Company age
19 yrs
Est. 2007
Employees · EPFO
32
Provident fund records
About Staywell Formulation Private Limited
Data last updated:
Staywell Formulation Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 November 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL2007PTC170595. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹2.84 Cr. It is led by directors Suresh Lal Santuka and Vikash Kumar Santuka.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at First Floor 14 Rani Jhansi Road, New Delhi, Delhi, India – 110055.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.54 Lakh, a decline of 100% compared to the previous year. For the same year it recorded a net loss of ₹76.67 Lakh and EBITDA of -₹17.82 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 88% over three years and 74% over five years.
The company has about 32 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹11.8 Cr and satisfied charges of ₹6.6 Cr on record. Court records list 23 cases involving the company, including 2 filed by the company and 21 filed against it; 1 case is pending.
Staywell Formulation Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-06-0002547). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24233DL2007PTC170595
Registration Number 170595
Incorporation Date 20 November 2007
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-UK-06-0002547
Recognitions & Rankings of Staywell Formulation
Contact details
Staywell Formulation Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFirst Floor 14 Rani Jhansi Road, New Delhi, Delhi, India – 110055
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Staywell Formulation Private Limited, buy the company report.
Comprehensive company report
Staywell Formulation Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Staywell Formulation is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Staywell Formulation Private Limited, buy the company report.
Financials of Staywell Formulation Private Limited
FY 2025 filings availableStaywell Formulation Private Limited reported revenue of ₹3.54 Lakh (down 100% YoY) for FY 2024.
Revenue · FY 2024
₹3.54 Lakh ▼ 100%
Net loss · FY 2024
₹76.67 Lakh
EBITDA · FY 2024
-₹17.82 Lakh
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
3 years · compounded
▼ 88%
5 years · compounded
▼ 74%
EBITDA CAGR growth
1 year
▼ 117%
3 years · compounded
▼ 28%
5 years · compounded
▼ 16%
Revenue has declined at a compounded annual rate (CAGR) of 74% over five years. EBITDA fell 117% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹17.82 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹76.67 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Staywell Formulation Private Limited, buy the company report.
Board of directors of Staywell Formulation Private Limited
Staywell Formulation has 2 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suresh Lal Santuka | Director | 21 Dec 2015 | 10 Years 10 Months | Current |
| Vikash Kumar Santuka Also directs: Santuka Associates Private Limited, S A Logistics Private Limited | Director | 21 Dec 2015 | 10 Years 10 Months | Current |
Auditor
Staywell Formulation Private Limited is audited by PRAVEEN K. GUPTA & CO. for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PRAVEEN K. GUPTA & CO. | FY 2022 | 06257C |
Shareholding
The shareholding of Staywell Formulation Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Staywell Formulation Private Limited, buy the company report.
Charges & borrowings
Open charges
₹11.8 Cr
Satisfied charges
₹6.6 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Mar 2012 | 10347346 | Dena Bank | ₹11.8 Cr | Open | |
| 27 Mar 2010 | 10220401 | Canara Bank | ₹80 Lakh | Satisfied | |
| 30 Mar 2009 | 10158621 | Canara Bank | ₹50 Lakh | Satisfied | |
| 30 Mar 2009 | 10158622 | Canara Bank | ₹3.3 Cr | Satisfied | |
| 30 Mar 2009 | 10158623 | Canara Bank | ₹2 Cr | Satisfied |
To see the full charge records of Staywell Formulation Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
Staywell Formulation Private Limited has 23 court cases on record: 2 filed by Staywell Formulation, 21 filed against it. 1 case is pending and 22 are disposed.
Total cases
23
Filed by the company
2
Filed against the company
21
Pending
1
Disposed
22
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 17 | 17 | 1 |
| High courts | 6 | 4 | 0 |
Cases on record (5 of 23)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Civil suit | Filed against the company by Aren Pharma Care Pvt.Ltd. | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Court case (Chamber Summons) | Filed against the company by Aren Pharma Care Pvt.Ltd. | Disposed |
| High Court of Delhi | Court case (CCP(CO.)) | Filed against the company by Del Trade International Private Limited | Disposed |
| High Court of Delhi | Court case (CRL.M.(CO.)) | Filed against the company by Del Trade International Private Limited | Disposed |
| High Court of Delhi | Court case (CRL.M.(CO.)) | Filed by the company against Del Trade International Private Limited | Disposed |
To see the full case history of Staywell Formulation Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Staywell Formulation Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 6 overdue payments to 3 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (3 of 3)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Staywell Formulation Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Staywell Formulation Private Limited has a workforce of 32 employees on its EPFO records as of Apr 03, 2024, across 2 active EPFO establishments.
Employee count
32
Active EPFO establishments
2
Employee growth
-41.82%
GST
Staywell Formulation has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
Total GSTINs
1
Cancelled / inactive
1
To see the full GST registrations and return filing status of Staywell Formulation Private Limited, buy the company report.
Recent activity
Staywell Formulation Private Limited has 11 board changes on record since 2008: 2 appointments and 9 cessations. The latest: Ruchi Tyagi ceased to be Director on 06 Jun 2023.
AGM
Staywell Formulation Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Staywell Formulation Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Ruchi Tyagi ceased to be Director.
Ceased
Surendra Singh Pokhariyal ceased to be Director.
Ceased
Vivek Goel ceased to be Director.
Ceased
Tarun Goel ceased to be Director.
Appointed
Suresh Lal Santuka was appointed as Director.
Appointed
Vikash Kumar Santuka was appointed as Director.
Charges
A charge with Dena Bank of Rs. 11.80 Cr registered on 19 Mar 2012 with Charge ID 10347346 was modified on 30 Dec 2014.
Ceased
Ashok Bansal ceased to be Director.
Charges
A charge registered on 27 Mar 2010 via Charge ID 10220401 with Canara Bank was fully satisfied on 22 Apr 2013.
Charges
A charge registered on 30 Mar 2009 via Charge ID 10158621 with Canara Bank was fully satisfied on 22 Apr 2013.
13 earlier events are in the company report.
Frequently asked questions
Staywell Formulation is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 November 2007 (19+ years old) and is registered under CIN U24233DL2007PTC170595.
Staywell Formulation has 2 current directors:
- Suresh Lal Santuka - Director
- Vikash Kumar Santuka - Director
The latest financial statements of Staywell Formulation on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Staywell Formulation has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Staywell Formulation is U24233DL2007PTC170595. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Staywell Formulation has 23 court cases on record: 2 filed by the company and 21 filed against it. 1 is pending. Most are in the district courts.
Staywell Formulation was incorporated on 20 November 2007, making it 19+ years old. It is registered with the Registrar of Companies, Delhi.
Ruchi Tyagi ceased to be Director on 06 Jun 2023. Surendra Singh Pokhariyal ceased to be Director on 06 Jun 2023. Vivek Goel ceased to be Director on 31 Mar 2019. Staywell Formulation has 11 board changes on record in total.
Yes, Staywell Formulation is registered as a small enterprise under Udyam registration (number: UDYAM-UK-06-0002547).
Staywell Formulation has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 6 overdue payments to 3 micro and small suppliers. The latest return was filed on 18 Jun 2019.
The registered office of Staywell Formulation is at First Floor 14 Rani Jhansi Road, New Delhi, Delhi, India – 110055.